Clinical Trials in Pittsburgh

Showing 9601-9620 of 16,007 trials

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

NCT01602614

This is a clinical sampling study, and no study drugs will be administered under this protocol. Premature infants who receive intravenous ganciclovir as part of clinical care will be eligible for participation in this study. Intravenous ganciclovir will not be provided under this protocol.

Cytomegalovirus Infections

University of Alabama at Birmingham18 participantsStarted Apr 2013

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Washington D.C., District of Columbia, United States +12 more locations

COMPLETED< 1 mile

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

NCT03112694

The purpose of this study is to understand how people with neuroendocrine tumors respond to treatment with lanreotide after having received treatment with octreotide.

Neuroendocrine Tumors

Ipsen93 participantsStarted Apr 2017

Tampa, Florida, United States • Wichita, Kansas, United States • New Orleans, Louisiana, United States +5 more locations

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Find Trials by Condition in Pittsburgh

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

Immunotherapy Study for Surgically Resected Pancreatic Cancer

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Vaccine Study for Surgically Resected Pancreatic Cancer

Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer

Transvenous Lead Removal Post-Market Clinical Study

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Safety Study of ECO Conversion System For Red Blood Cells.

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

Non-invasive Buttock Lifting Induced by Magnetic Device - Multicentric Study

ENABLE: CHF-PC (Comprehensive Heartcare For Patients and Caregivers)

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma